Estimations des analystes de Wall Street pour Dyne Therapeutics, Inc. (DYN): objectif de cours de consensus, recommandations achat/conserver/vente et prévisions de revenus, BPA et EBITDA pour les prochains exercices.
Surprises de Résultats Récentes
| Date | BPA Réel | BPA Estimé | vs Est. |
|---|---|---|---|
| 2026-11-04 | $-0.88 | ||
| 2026-07-30 | $-1.08 | $-0.75 | -44.2% |
| 2026-05-11 | $-0.73 | $-0.77 | +5.5% |
| 2026-03-02 | $-0.76 | $-0.74 | -2.7% |
| 2025-11-05 | $-0.76 | $-0.81 | +6.2% |
| 2025-07-28 | $-0.97 | $-0.99 | +2.0% |
| 2025-05-08 | $-1.05 | $-0.88 | -19.3% |
| 2025-02-27 | $-0.88 | $-0.92 | +4.3% |
Ratios de valorisation
| Prix / Valeur comptable | 4.12 |
| Rendement du dividende | 0.00% |
Compte de Résultat (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenus | $1.37B | $506.0M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Coût des Ventes | $2.28B | $2.93B | $24000 | $271000 | $700000 | 0 | 0 | $2.5M | $2.2M | $2.0M |
| Marge Brute | -$915.0M | -$2.43B | -$24000 | -$271000 | -$700000 | 0 | 0 | -$2.5M | -$2.2M | -$2.0M |
| R&D | 0 | 0 | $4.3M | $11.0M | $45.2M | $121.3M | $142.8M | $210.8M | $281.4M | $398.3M |
| Frais Généraux | $161.0M | $189.0M | $517000 | $2.8M | $12.7M | $28.7M | $28.2M | $31.4M | $62.5M | $69.9M |
| Charges Opérationnelles | $161.0M | $189.0M | $4.8M | $13.8M | $57.9M | $150.0M | $171.0M | $239.7M | $341.6M | $466.1M |
| Résultat Opérationnel | -$640.0M | -$412.0M | -$4.8M | -$13.8M | -$58.6M | -$150.0M | -$171.0M | -$242.2M | -$343.9M | -$468.2M |
| EBITDA | $106.0M | $949.0M | -$4.8M | -$14.6M | -$58.3M | -$148.2M | -$163.5M | -$233.5M | -$315.2M | -$438.0M |
| Charges d'Intérêt | $625.0M | $616.0M | $5000 | 0 | $396000 | 0 | $2.9M | 0 | 0 | $6.2M |
| Résultat Avant Impôts | -$1.29B | -$538.0M | -$4.8M | -$14.9M | -$59.4M | -$149.3M | -$168.1M | -$235.9M | -$317.4M | -$446.2M |
| Impôts | -$45.0M | -$610.0M | -$11000 | 0 | -$700000 | 0 | 0 | 0 | 0 | 0 |
| Résultat Net | -$1.24B | $76.0M | -$4.8M | -$13.5M | -$58.7M | -$149.3M | -$168.1M | -$235.9M | -$317.4M | -$446.2M |
| BPA | $-9.61 | $0.47 | $-0.47 | $-0.30 | $-1.24 | $-2.93 | $-3.23 | $-3.95 | $-3.37 | $-3.47 |
| BPA Dilué | $-9.61 | $0.47 | $-0.47 | $-0.30 | $-1.24 | $-2.93 | $-3.23 | $-3.95 | $-3.37 | $-3.47 |
| Actions en Circulation (Diluées) | $129.0M | $162.0M | $10.3M | $45.4M | $47.3M | $50.9M | $52.0M | $59.7M | $94.1M | $128.4M |
Prix
| Prix | $17.30 |
| Capitalisation | $3.2B |
| Bourse | NASDAQ |
| Pays | US |
Entreprises liées: AAPG · APGE · CELC · CGON · CNTA · MIRM · RARE
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de DYN: Vue d'ensemble · Financiers · Valorisation · Statistiques · Technique · Actionnariat · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions